Skip to content
Catalyst

PapersPMID:35774540

Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.

Frontiers in nutrition2022The record ↗

findings
6
compound
1
endpoints
6
PMID:35774540
  1. Finding, moderate evidencelowersInterleukin-6 concentration
  2. Finding, moderate evidencelowersIntensive care unit length of stay
  3. Finding, moderate evidencelowersTumour necrosis factor alpha concentration
  4. Finding, moderate evidencelowersHospital length of stay
  5. Finding, limited evidencelowersAlanine aminotransferase
  6. Finding, limited evidencelowersAspartate aminotransferase
Study, every finding
meta-analysis
Population, every finding
Severe acute pancreatitis patients, pooled across parenteral and enteral glutamine-supplemented nutrition trials
  • “The results indicated that Gln supplementation effectively reduced IL-6 levels (SMD = −1.23, 95% CI: −1.68 to −0.78, P < 0.00001; Figure 17).”
    Effect
    −1.23 standardised mean difference, 95% CI −1.68 to −0.78
  • “The pooled results indicated that Gln supplementation was associated with a significantly shorter ICU hospital stay (SMD = −0.93, 95% CI: −1.83 to −0.04, P = 0.04; Figure 6).”
    Effect
    −0.93 standardised mean difference, 95% CI −1.83 to −0.04
  • “The combined results showed that nutritional supplementation with Gln was effective in reducing TNF-α levels (SMD = −2.47, 95% CI: −3.27 to −1.66, P < 0.00001; Figure 19).”
    Effect
    −2.47 standardised mean difference, 95% CI −3.27 to −1.66
  • Decreases hospital length of stay

    moderatereplicated ×3

    “The pooled results showed that Gln supplementation significantly reduced the total length of hospital stay (MD = −3.41, 95% CI: −4.93 to −1.88, P < 0.0001; Figure 7).”
    Effect
    −3.41 mean difference, 95% CI −4.93 to −1.88
  • “We selected a random-effects model, and the pooled estimates suggested that Gln supplementation significantly reduced ALT level (MD = −13.73, 95% CI: −16.40 to −11.07, P < 0.00001; Figure 11).”
    Effect
    −13.73 mean difference, 95% CI −16.4 to −11.07
  • “The meta-analysis results showed that Gln supplementation was more effective in reducing AST level (MD = −21.45, 95% CI: −34.74 to −8.16, P = 0.002; Figure 7).”
    Effect
    −21.45 mean difference, 95% CI −34.74 to −8.16

Study record

Design
meta-analysis
Species
human
Population
adults with severe acute pancreatitis (SAP); experimental arms received enteral or parenteral nutrition supplemented with glutamine, compared with conventional nutrition without glutamine; 30 pooled RCTs. Total enrollment is reported as 1,201 in the abstract but 915 (experimental) + 917 (control) = 1,832 in the Results section.
Participants
1,832
Comparator
placebo
Duration
not reported
Endpoints measured
20